Gates Foundation

PHOENIXVILLE, Pa., June 20, 2026 PleoPharma, Inc. has announced the dosing of the first patient in CAN-004, its pivotal...

SAN DIEGO, Calif., June 20, 2026 Replicate Bioscience has secured a $3 million research grant from the Gates Foundation...

CAMBRIDGE, Mass. & HOUSTON, April 9, 2026 Decoy Therapeutics, Inc. is rapidly gaining momentum as it enters a highly...